Carbavim

Carbavim may be available in the countries listed below.

Ingredient matches for Carbavim

Carbamazepine

Carbamazepine is reported as an ingredient of Carbavim in the following countries:

• Romania

International Drug Name Search

Newmazole

Newmazole may be available in the countries listed below.

Ingredient matches for Newmazole

Carbimazole

Carbimazole is reported as an ingredient of Newmazole in the following countries:

• Taiwan

International Drug Name Search

Naprosyn

Naprosyn is a brand name of naproxen, approved by the FDA in the following formulation(s):

NAPROSYN (naproxen - suspension; oral)

• 
  Manufacturer: ROCHE PALO
  
  Approval date: March 23, 1987
  
  Strength(s): 25MG/ML ^[RLD][AB]

NAPROSYN (naproxen - tablet; oral)

• 
  Manufacturer: ROCHE PALO
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 250MG ^[AB], 375MG ^[AB]


• 
  Manufacturer: ROCHE PALO
  
  Approval date: April 15, 1982
  
  Strength(s): 500MG ^[RLD][AB]

Has a generic version of Naprosyn been approved?

Yes. The following products are equivalent to Naprosyn:

naproxen suspension; oral

• 
  Manufacturer: ROXANE
  
  Approval date: March 30, 1994
  
  Strength(s): 25MG/ML ^[AB]

naproxen tablet; oral

• 
  Manufacturer: AMNEAL PHARMS NY
  
  Approval date: December 18, 2001
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA USA
  
  Approval date: November 8, 2011
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: DAVA PHARMS INC
  
  Approval date: April 28, 1995
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: GLENMARK GENERICS
  
  Approval date: March 28, 2007
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: INVAGEN PHARMS
  
  Approval date: August 24, 2011
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: MARKSANS PHARMA
  
  Approval date: February 14, 2011
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: December 21, 1993
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: PERRIGO R AND D
  
  Approval date: April 27, 2005
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: December 21, 1993
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: December 21, 1993
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: May 31, 1995
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: WESTWARD
  
  Approval date: January 14, 2004
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA
  
  Approval date: June 7, 2007
  
  Strength(s): 250MG ^[AB], 375MG ^[AB], 500MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Naprosyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Naprosyn.

See also...

• Naprosyn Consumer Information (Drugs.com)
• Naprosyn Consumer Information (Wolters Kluwer)
• Naprosyn Suspension Consumer Information (Wolters Kluwer)
• Naprosyn Consumer Information (Cerner Multum)
• Naprosyn Advanced Consumer Information (Micromedex)
• Naproxen Consumer Information (Drugs.com)
• Naproxen Consumer Information (Wolters Kluwer)
• Naproxen Enteric-Coated Tablets Consumer Information (Wolters Kluwer)
• Naproxen Suspension Consumer Information (Wolters Kluwer)
• Naproxen Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Naprelan 375 Consumer Information (Cerner Multum)
• Naprelan 500 Consumer Information (Cerner Multum)
• Naprelan 750 Consumer Information (Cerner Multum)
• Naproxen Consumer Information (Cerner Multum)
• Naprelan 500 Advanced Consumer Information (Micromedex)
• Naprelan Dose Card Advanced Consumer Information (Micromedex)
• Naxen Advanced Consumer Information (Micromedex)
• Naproxen Advanced Consumer Information (Micromedex)
• Naproxen AHFS DI Monographs (ASHP)
• Naproxen Sodium AHFS DI Monographs (ASHP)

Betafusin

Betafusin may be available in the countries listed below.

Ingredient matches for Betafusin

Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Betafusin in the following countries:

• Greece

Fusidic Acid

Fusidic Acid is reported as an ingredient of Betafusin in the following countries:

• Greece

International Drug Name Search

Carbostine

Carbostine may be available in the countries listed below.

Ingredient matches for Carbostine

Carbocisteine

Carbocisteine is reported as an ingredient of Carbostine in the following countries:

• Tunisia

International Drug Name Search

Gallbladder Contraction Medications

Drugs associated with Gallbladder Contraction

The following drugs and medications are in some way related to, or used in the treatment of Gallbladder Contraction. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Drug List:

Kinevac

Fluosmin

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Fluosmin

Flumetasone

Flumetasone 21-acetate (a derivative of Flumetasone) is reported as an ingredient of Fluosmin in the following countries:

• United States

International Drug Name Search